Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion

Retina

Volumn 25, Issue 7, 2005, Pages 856-860

  Karacorlu, Murat ^a   Ozdemir, Hakan ^a   Karacorlu, Serra Arf ^a  

^a Istanbul Retina Institute Inc   (Turkey)

Author keywords

Branch retinal vein occlusion; Cystoid macular edema; Intravitreal triamcinolone acetonide; Serous macular detachment

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA CYSTOID EDEMA; RETINA MACULA DEGENERATION; RETINA VEIN OCCLUSION; RISK ASSESSMENT; VISUAL ACUITY;

AGED; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RETINAL DETACHMENT; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 26844568732     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200510000-00007     Document Type: Article

References (20)

1. Schatz H, Yannuzzi L, Strasky TJ. Retinal detachment secondary to branch vein occlusion: part I. Ann Ophthalmol 1976;8:1437-1452.
2. Schatz H, Yannuzzi L, Strasky TJ. Retinal detachment secondary to branch vein occlusion: part II. Ann Ophthalmol 1976;8:1461-1471.
3. Parodi M, Isola V. Branch retinal vein occlusion and exudative retinal detachment: pathological aspects. Ophthalmologica 1994;208:29-31.
4. Weinberg D, Jampol LM, Schatz H, Brady K. Exudative retinal detachment following central and hemicentral retinal vein occlusions. Arch Ophthalmol 1990;108:271-275.
5. Spaide RF, Lee JK, Klancnik JM, Gross NE. Optical coherence tomography of branch retinal vein occlusion. Retina 2003;23:343-347.
6. Danis RP, Ciulla TA, Pratt LM, Ankliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-250.
7. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002;120:1217-1219.
8. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
9. Karacorlu M, Ozdemir H, Karacorlu S. Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular edema. Acta Ophthalmol Scand 2003;81:648-652.
10. Chen SDM, Lochhead J, Patel CK, Frith P. Intravitreal triamcinolone acetonide for ischaemic macular edema caused by branch retinal vein occlusion. Br J Ophthalmol 2004;88:154-155.
11. Weinberg D, Jampol LM, Schatz H, Brady KD. Exudative retinal detachment following central and hemicentral retinal vein occlusions. Arch Ophthalmol 1990;108:271-275.
12. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999;27:688-693.
13. Lerche RC, Schaudig U, Scholz F, Walter A, Richard G. Structural changes of the retina in retinal vein occlusion. Imaging and quantification with optical coherence tomography. Ophthalmic Surg Lasers 2001;32:272-280.
14. Kokame GT, de Leon MD, Tanji T. Serous retinal detachment and cystoid macular edema in hypotony maculopathy. Am J Ophthalmol 2001;131:384-386.
15. Ravalico G, Battaglia PM. Exudative retinal detachment subsequent to retinal vein occlusion. Ophthalmologica 1992;205:77-82.
16. Kang SW, Park CY, Ham D. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 2004;137:313-322.
17. Vinores SA, Youssri AL, Luna JD, et al. Up-regulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997;12:99-109.
18. Spaide RF, Goldbaum M, Wong DWK, Tang KCT, Ilda T. Serous detachment of the retina. Retina 2003;23:820-846.
19. Penfold PL, Wong JG, Gyory J, Billson FA. Effects of triamcinolone acetonidepn microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clin Exp Ophthalmol 2001;29:188-192.
20. Penfold PL, Wen L, Madigan MC, Gillies MC, King NJ, Provis JM. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol 2000;121:458-465.